RxDoctor Payments Data

Valerie Harvey, MD

Dermatology · Newport News, VANPI 1427027978

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $19,570 of the $25,956 with a category attached, or 75.4%. 31 manufacturers reported payments, led by Eli Lilly at 30.6% of the total. Reporting peaked in 2023 at $6,784 and has fallen 92.2% since, to $531 in 2025. Among dermatology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,956in general payments, 2019–2025

Across 276 payments — averaging $94.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$8K
  • Novartis$5K
  • E.r. Squibb & Sons, L.L.C.$4K
  • Johnson & Johnson$2K
  • UCB, Inc.$2K
  • Janssen Scientific Affairs, LLC$2K
  • plus $4K from 25 others

What the payments were for

  • Consulting fees$19,57075%
  • Travel & lodging$7073%
  • Food & beverage$5,31720%
  • Education$3621%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,956 in reported general payments places this provider in the 90th percentile of 396 dermatology providers in Virginia.

See all dermatology providers in Virginia

Medicare billing

Part B allowed, 2024
$241,385
Medicare patients
1,225
Services billed
4,026

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab28$103,962
Cosentyx Sensoready (2 Pens)Secukinumab13$98,040
Dupixent SyringeDupilumab14$50,243
Clobetasol Propionate179$8,062
Tacrolimus31$4,431
Clindamycin Phosphate39$2,545
Metronidazole35$2,192
Dapsone11$1,987
Ketoconazole132$1,910
Tretinoin18$1,668
Doxycycline Hyclate65$1,577
Azelaic Acid16$1,229
Triamcinolone Acetonide124$1,195
Betamethasone Dipropionate23$996
Ammonium Lactate28$772

Paid to pharmacies, not to this prescriber.

Other dermatology in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →